Stockreport

BioCardia Reports Third Quarter 2025 Business Highlights and Financial Results

BioCardia, Inc.  (BCDA) 
PDF SUNNYVALE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiov [Read more]